GROWTH HORMONE-PRODUCING PITUITARY TUMOUR

GROWTH HORMONE-PRODUCING PITUITARY TUMOUR was reported 32 times

GROWTH HORMONE-PRODUCING PITUITARY TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen [EPC] 13 0.0005
1 Ergot Derivative [EPC] 2 0.0004
2 Somatostatin Analog [EPC] 1 0.0001
3 Anti-epileptic Agent [EPC] 16 0.0001
4 Mood Stabilizer [EPC] 15 0.0001
5 Atypical Antipsychotic [EPC] 15 0.0000
6 5-alpha Reductase Inhibitor [EPC] 3 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Opioid Agonist [EPC] 6 0.0000
9 Corticosteroid [EPC] 17 0.0000
10 Anti-IgE [EPC] 1 0.0000
11 Prostaglandin Analog [EPC] 1 0.0000
12 Osmotic Laxative [EPC] 2 0.0000
13 Thiazide Diuretic [EPC] 1 0.0000
14 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
15 Insulin Analog [EPC] 1 0.0000